000			02269 a2200661 4500
005			20250517014825.0
264		0	_c20150521
008			201505s 0 0 eng d
022			_a1432-0851
024	7		_a10.1007/s00262-015-1656-x _2doi
040			_aNLM _beng _cNLM
100	1		_aKlein, Oliver
245	0	0	_aLow-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma. _h[electronic resource]
260			_bCancer immunology, immunotherapy : CII _cApr 2015
300			_a507-18 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntigens, Neoplasm _ximmunology
650	0	4	_aAntineoplastic Agents, Alkylating _xadministration & dosage
650	0	4	_aCD4-Positive T-Lymphocytes _ximmunology
650	0	4	_aCancer Vaccines _xadministration & dosage
650	0	4	_aCholesterol _ximmunology
650	0	4	_aCohort Studies
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Combinations
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLymphatic Metastasis
650	0	4	_aMale
650	0	4	_aMelanoma _ximmunology
650	0	4	_aMembrane Proteins _ximmunology
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aPhospholipids _ximmunology
650	0	4	_aPrognosis
650	0	4	_aSaponins _ximmunology
650	0	4	_aT-Lymphocytes, Regulatory _ximmunology
700	1		_aDavis, Ian D
700	1		_aMcArthur, Grant A
700	1		_aChen, Li
700	1		_aHaydon, Andrew
700	1		_aParente, Phillip
700	1		_aDimopoulos, Nektaria
700	1		_aJackson, Heather
700	1		_aXiao, Kun
700	1		_aMaraskovsky, Eugene
700	1		_aHopkins, Wendie
700	1		_aStan, Rodica
700	1		_aChen, Weisan
700	1		_aCebon, Jonathan
773	0		_tCancer immunology, immunotherapy : CII _gvol. 64 _gno. 4 _gp. 507-18
856	4	0	_uhttps://doi.org/10.1007/s00262-015-1656-x _zAvailable from publisher's website
999			_c24604914 _d24604914